Fifth Third Bancorp’s RxSight RXST Stock Holding History

Fifth Third Bancorp’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$116	Hold	24	–	–	﹤0.01%	4303
2026 Q1	$148	Buy	+24	New	+$199	﹤0.01%	4257

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fifth Third Bancorp's RXST Position: Q2 2026 in Review

Fifth Third Bancorp held its RxSight (RXST) position steady in Q2 2026 at 24 shares worth $116. The position accounts for ﹤0.01% of the portfolio, ranked #4303.

Fifth Third Bancorp first reported a position in RXST in Q1 2026 and has held it in 2 quarters since. The position peaked at $148 in Q1 2026. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Fifth Third Bancorp held 24 shares of RxSight worth $116 as of Q2 2026.
Fifth Third Bancorp left its RxSight share count unchanged in Q2 2026.
RxSight made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4303 holding.
Fifth Third Bancorp first reported a position in RxSight in Q1 2026 and has held it in 2 quarters since.
Fifth Third Bancorp's RxSight position peaked at $148 in Q1 2026.
152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.